Privacy details for coronavirus testing
You can now schedule a coronavirus (COVID-19) test at home or at a nearby testing facility thanks to the government's implementation of the program.
A PCR test is available online.
Calling 119 (free from mobile and landlines) will allow you to register for a test if you are having trouble using the online system.
The examination will determine whether you currently possess COVID-19. This will enable you to:
- the appropriate actions to take care of yourself
- safeguard others
- find out if you're healthy enough to go back to work.
You should not use any test you take that is covered by the NHS Test and Trace service for international travel. If necessary, you can purchase a private examination. This is to guarantee that those who need a test can access one.
According to the Reporting of Injuries, Diseases and Dangerous Occurrences Regulations 2013 (RIDDOR), your employer must notify the Health and Safety Executive if there is plausible evidence that you contracted COVID-19 due to an occupational exposure.
There are various test types you can take. Depending on the test selected, these tests can either be self-administered (i.e., completed by you) or staff-administered (i.e., completed by a member of staff). You might receive additional instructions regarding the website you're visiting as part of the test. An NHS site with facilities, like a hospital, may invite employees there.
If you and the people you live with are in an outbreak area, you might be given a home testing kit. You must register the home testing kit online following the provided instructions.
The examination is entirely optional. If you decide you no longer need the test you've scheduled, you can cancel it. If you decide to take the test, you must adhere to the guidelines given. We will send you a confirmation email with the specifics of your order or booking as part of the registration process. It is required that you bring this with you if you are visiting a test site.
Please be aware that NHS Digital is in charge of managing the identity verification services if you access our service using your NHS login information. View the terms and conditions and privacy notice for NHS Digital. The private data you give us separately is exempt from this restriction.
After you take the test, your sample will be examined in a lab, and you will receive text and/or email notifications with the test's outcome (positive, negative, or unclear). You will receive guidance on any necessary next steps after receiving your result.
Your information will be sent to NHS Digital if you reside in England. who will now send your personal information to the Department of Health and Social Care's (DHSC) Test and Trace data analysis platform, the UK Health Security Agency (UKHSA), and a central database held by NHSX and managed by NHS England. According to data protection requirements, all personal information in these databases is held securely, and access to your personal information is strictly controlled.
The public health authorities for residents of Wales, Scotland, and Northern Ireland have asked NHS Digital to compile your test results on their behalf so that they can be sent to the appropriate health authorities in these devolved nations to help them respond to COVID-19.
Visit NHS.UK's Testing for Coronavirus (COVID-19) page for more information about the testing program.
UKHSA was established on October 1st, 2021. An executive agency within DHSC, UKHSA combines all of the activities of the Joint Biosecurity Center (JBC), the NHS Test and Trace Program, and many of the health protection initiatives previously carried out by Public Health England (PHE). The data processors and processing activities remain the same. This modification has no effect on an individual's rights.
For the purposes of data protection law, DHSC has contracted with UKHSA on behalf of the UK government, and DHSC will continue to be the data controller.
In addition to providing intellectual, scientific, and operational leadership at the local, state, and federal levels as well as on the international stage, UKHSA is in charge of organizing, preventing, and responding to external health threats. UKHSA will make sure that the country is able to respond quickly and on a larger scale to pandemics and potential threats.
Read our general privacy notice for more information about what UKHSA accomplishes.
The Welsh, Scottish, and Northern Irish governments are being consulted by DHSC, and they may have testing procedures unique to their regions as well as country-specific data regarding COVID-19. Residents in Wales, Scotland, and Northern Ireland can find links to this information there.
Depending on what they are doing with your personal information at various stages of the process, other organizations, including research organizations, may also be data controllers.
Parts of the COVID-19 testing program will also be carried out by other organizations on DHSC's behalf, but they are only able to do so if DHSC gives them the go-ahead. These businesses are referred to as data processors. One such company is Royal Mail Group, which will assist in taking the necessary steps to deliver test kits to your home.
Each organization will need a different amount of information about you, but all will use only the bare minimum to accomplish the necessary goal as instructed by the data controller.
For a complete list, refer to the "Data Controllers and Data Processors" section.
Those who process your data as well as other recipients
Organizations that use your data and information for a controller may only do so in accordance with the controller's explicit instructions. These companies, which are known as data processors, are not allowed to use your data and information for any other reason. Without the controller's consent and written authorization, any use of your personal data that is not permitted by the controller's instructions is prohibited.
Data processors have been appointed by DHSC to:
- register for your exam
- Set up appointments and record data when testing occurs.
- Verify your QR code there
- Checking your identity as part of ordering a home test has no impact on your credit score and is not a credit check.
- control the delivery of test kit logistics
- connect the test result to the personal information you provided when you registered for the exam.
- Send the NHS Business Services Authority your test results, email address, and phone number so they can contact you with the results.
- receive information that will enable your results and supporting information to be communicated to you via text and email.
- Ensure that the processing of your test data is correct.
Various organizations in various regions may offer services on behalf of DHSC. Annexe 8 contains a complete list of data processors.
What private information we gather
From you, we glean the following information:
- full name (first and last names included)
- born on date
- other members of the family
- Only if you are an English resident and know the NHS number Residents of Wales, Scotland, and Northern Ireland may be required to submit a unique local identifier; this information will be provided when registering for a test.)
- company information
- Whether a test result was positive more than 90 days ago,
- If you use your NHS login information to access our services, your NHS login account identifier
- vaccine history
- time and information on COVID-19 symptoms
- residential and delivery addresses, along with a postcode
- area code post
- NHS number
- federal identification number
- mobile numbers
- the email address
- Number of the vehicle's registration (if scheduling a drive-in testing appointment)
- job title
- Passenger travel information (for instance, recent travel history, such as whether you recently traveled abroad and the country you spent the most time in)
- health information, including test results
- Close contact information, such as names and numbers of those you have had frequent contact with
- information about racial or ethnic origin
- DNA information
- whether you need additional support or are clinically vulnerable
We will also gather and process the results of your COVID-19 test, whether they are positive, negative, or unclear, in order to let you know what they mean and the next steps you should take.
The program for testing
Depending on which test kit you receive, different home test kit suppliers may have slightly different procedures.
Your name and address will be given to our delivery service, such as Royal Mail Group, who will deliver the testing kit if you have registered for a home test or have received one because you live in an outbreak area.
There will be a special reference number on the test kit. You must adhere to the test kit's instructions after self-administrating the test. Completed test kits must be delivered to a laboratory for analysis where a courier will pick them up or they must be mailed via priority mail box.
You will be given a QR code if you scheduled an appointment at a local test site. When you arrive at the location, you must scan this QR code to register.
Before returning the test kit, you must register the barcode that was assigned to you when you took the test. Then, a laboratory will receive the finished tests for analysis.
Your test sample will be analyzed by the lab, and the National Pathology Exchange (NPEx) will receive your test results. The only piece of personal information the lab receives from you is the specimen ID from the test kit, which it uses to associate your test result with the specimen ID. Now that NPEx has connected your registration record with your test result, it will transmit this information to NHS Business Services Authority, which will send you a text message or email with your test result.
Also, NPEx will
- Send results to NHS Digital so they can gather information and data for all of the UK's countries.
- By receiving your GP information from NHS Digital or UKHSA and sending your results to your GP, you can link the results to your medical records (for English residents only). NHS Digital will attempt to match records where NPEx is unable to. This will allow your GP to be informed of the results of your test without you having to take any action.
Your results will be sent to Public Health Wales, NHS National Services Scotland, and Northern Ireland public health organizations for Welsh, Scottish, and Northern Irish residents, respectively, so they can respond to COVID-19.
Visit NHS.UK to learn when to stay at home and what to do.
If you test positive after taking a COVID-19 test:
- A few weeks after the date of your test result, DHSC may get in touch with you and invite you to undergo an antibody test. Additionally voluntary, you are not required to take this examination. If you decide to undergo an antibody test, you will be given the opportunity to sign up for a test that is similar to this one. When you register, please follow the instructions provided to you.
- DHSC may also get in touch with you via email or text message to ask if you'd like to donate blood plasma as part of a possible coronavirus cure.
If you test positive or negative, DHSC may also get in touch with you to ask if you'd like to help with the COVID-19 research project. Follow the link in the text message if you're interested in doing this.
Uses to which your information will be put
DHSC is in charge of data processing for the following reasons:
- confirming your test date and time at the test location
- checking the QR code at the test location
- getting your COVID-19 test and processing it
- returning to you the results of your test
- Sharing your findings with Welsh, Scottish, and Northern Irish health organizations (if you reside there) would help local planning and COVID-19 responses.
- if you reside in England, sharing findings with UKHSA to assist in planning and implementing COVID-19
- In order to evaluate the efficacy of COVID-19 vaccines, including their efficacy against various strains or variants of the COVID-19 virus, and, where appropriate, to request that you undergo a repeat test and/or an antibody test, you must share your vaccination status with UKHSA (if you reside in England).
- If you live in England, you should let your local authority know that you are self-isolated so they can check any applications you may have made for a self-isolation support payment.
- if you are scheduled for elective surgery, sending your COVID-19 test results to your neighborhood hospital (via your Summary Care Record) This only applies if you have a Summary Care Record and have taken the test.
- submitting your findings to NHS Digital (if you reside in England) for data analysis related to COVID-19
- implementing quality control measures for the testing procedure (such as clinical process assurance)
- requesting the data processors to share their data with researchers The data processor will manage this data with the necessary data security.
- To ensure that the tests being submitted to laboratories flow across approved systems and are processed in these systems in accordance with mandated procedures, the NHS Test and Trace systems are monitoring the test data flow throughout their systems (this is also referred to as test flow monitoring).
- for analysis to support operational choices to enhance the comprehensive end-to-end testing procedure, including:
- daily use (for instance, whether someone showed up for an appointment)
- to update local test sites on process enhancements (such as managing capacity or throughput).
- assisting in the planning of end-to-end logistics
- contacting you to request your participation in a survey to learn more about the attitudes and actions associated with reporting LFD results
Additionally, your information might be used for other purposes unrelated to your health and care. We will use anonymous data (information that cannot be used to identify you) whenever possible. These consist of:
- COVID-19 investigation (possibly including being contacted about a research project)
- evaluation of new COVID-19 diagnostic products for use in services
- preparation of services or responses to COVID-19
- tracking the development and progress of COVID-19
- evaluating the suitability and appropriateness of new initiatives and use cases for pandemic management to COVID-19
No purpose unrelated to preventing the spread of COVID-19 will be served by the use of the information you provide and that is gathered about you in connection with COVID-19 testing.
Your personal information might occasionally need to be used. Any disclosure of information that could be used to identify you will be authorized and, at the very least, required for that purpose.
By law, DHSC and NHS England must work with NHS Digital to gather, analyze, and share COVID-19-related data only when other healthcare organizations or academics specifically request it. This data may be gathered from various healthcare organizations and provided to additional healthcare and research organizations that are addressing or researching COVID-19.
If you reside in England or Wales, it is not always necessary to obtain your consent before using your personal information to get in touch with you or inquire about your interest in participating in health research. For instance, the law permits this to occur where it has been authorized by the Secretary of State or the Health Research Authority to allow for the conduct of authorized medical research. Therefore, where permitted by law, you may still be asked to participate in COVID-19 vaccine studies without your consent, but this does not obligate you to do so.
Links to this information are available for residents of Wales, Scotland, and Northern Ireland in the section titled Residents of Wales, Scotland, and Northern Ireland.
Legal foundation under the 2018 Data Protection Act and UK GDPR
Your personal data is processed by DHSC on the following legal bases:
- GDPR Article 6(1)(e): The processing is required to carry out its official duties in the public interest, such as managing and providing health services.
- The processing is required for the administration of health/social care systems or services, according to GDPR Article 9(2)(h).
- Article 9(2)(i) of the GDPR states that the processing is required for public health purposes.
- Schedule 1, Part 1, (2) (2) (f) of the Data Protection Act of 2018 - health or social care purposes
Other businesses that handle your data will either have a contract in place with DHSC to do so (such as NHS Digital) or have a legal justification of their own.
You have certain legal rights as a data subject, and this testing program does not eliminate or limit any of those rights.
They are as follows:
- your right to obtain copies of the information about you that is used; you have the right to request a copy of any such information.
- you have the right to request the correction of any information that you believe is inaccurate that is being held about you.
- your right to limit how your information is used: If you believe that inaccurate information about you is being used, for example, you have the right to request that any information that is held about you be restricted.
- Your right to object to the use of your information - You have the right to request that any information that is kept about you not be used. However, this is not a guaranteed right, so we might still need to use your information. Whenever this occurs, we will let you know.
- your right to have information deleted; however, this right is not absolute, as we may still need to use your information. Whenever this occurs, we will let you know.
To address your concerns or file a complaint regarding how your personal information is used in connection with this program, you should first contact DHSC. To resolve your complaint, DHSC might need to work with partner organizations (for instance, if you have a complaint about Randox test kits, DHSC would work with Randox to address this).
You can file a complaint with the Information Commissioner's Office if you're still not satisfied.
Keeping and storing your data
In accordance with the Records Management Code of Practice for Health and Social Care 2021, we must keep your personal information for up to 8 years. If necessary, however, we may delete it earlier. Residents of Wales, Scotland, or Northern Ireland can find information on record retention in their respective countries by visiting Residents living in Wales, Scotland, or Northern Ireland.
Your personal data will be processed in the UK and stored securely. It is possible for information (such as data purely pertaining to the quantity of tests carried out or the quantity of test results) to be stored and processed outside of the UK.
Officer for Data Protection
Lee Cramp is the DHSC's data protection officer, and you can reach him at [email protected].
List of data processors and data controllers
The testing program's data controllers are:
- The central database that results go to, allowing organizations to respond to COVID-19, is managed by NHS England.
- Using NHS Digital
- granting NPEx access to your NHS number and registered GP information (found in NHS Digital's Personal Demographics Service) so that your test results can be sent to your GP
- sending data on residents to Public Health Wales, NHS National Services Scotland, and Northern Ireland public health bodies (respectively), who have asked NHS Digital to process data pertaining to their resident population for COVID-19.
- running the NHS's "Ask for a coronavirus test service" UK test reservation website for the general public
- linking your result to your doctor's file if NPEx cannot confidently match the details
- Any personal information you provided to NHS Digital in order to obtain an NHS login account and prove your identity is controlled by NHS Digital, and it is only used for that specific purpose. DHSC's role as a "processor" of this personal information is limited, and we must follow NHS Digital's rules as the "controller" when confirming your identity.
- When they receive the results, UKHSA plans its response to COVID-19 and uses them to find contacts.
- When receiving data to conduct COVID-19-related research, research organizations
Annexe 8 contains a complete list of data processors for the testing program.
Transfers of data internationally
The World Health Organization (WHO) may receive personal information as part of an international coordinated response to the COVID-19 pandemic. These personal data transfers are made in accordance with Article 49(1)(d) of the UK General Data Protection Regulation, which states that we must make the restricted transfer when it is in the public interest.
Personal information that does not identify you is sent to other data controllers in the US for some COVID-19 and vaccine trials so they can use it for the purposes outlined in this privacy notice. We have agreements in place with these data controllers that follow the ICO's Data Sharing Code of Practice. which guarantees the security of your data and that these transfers are made in accordance with Article 46(2)(c) of the UK General Data Protection Regulation - where we must make the restricted transfer for vital public interest reasons.
An exhaustive list of those who have received your personal information is included in Annexe 8 of this privacy notice.
To safeguard any information, we implement the necessary organizational, technical, and administrative security measures. Our Chief Information Security Officer is in charge of this. We have written procedures and policies that are periodically audited. The audits are also externally audited by third party assurance providers, and occasionally by the regulator (the Information Commissioner's Office).
Automated judgments or profiling
According to DHSC, section 2A of the NHS Act (2006), which allows the Secretary of State to take any actions he deems necessary to protect the public health, authorizes any automated decision-making.
Modifications to this rule
We regularly review our privacy notice, and any updates will be posted on our privacy notice page on GOV. UK
You can find more details about how your government will use your information (which varies by country) if you reside in Wales, Scotland, or Northern Ireland here:
- Ireland, Northern
Care-home testing in Annexe 1,
There are no direct national restrictions against visiting nursing homes.
As the government's capacity to test the populace has grown, testing is also being implemented at nursing homes and other similar types of residences, including:
- residential dwellings
- care facilities
- hospices, including those that offer home care
- a local authority's management of children's homes
The following list is not all-inclusive, and the word "home" is used to refer to these different types of housing.
Any person whose primary residence is one of the above-listed (or comparable) types of homes is referred to as a "resident."
Regardless of whether you have COVID-19 symptoms, all residents are eligible for a test. The following options are available for how to conduct this test:
- The home's manager will create an account on GOV. UK through a special care facility portal for the number of home test kits they require for their residents and staff, then register each person separately (so the test kit number can be linked to your details) The tests will be carried out by the facility's staff, and they will then be picked up by a courier and sent for analysis.
- A testing unit will visit the facility and conduct tests on all of the residents and employees there that day.
The test is optional, so you are not required to take it.
The manager can provide the mobile testing unit with the information for residents who are unable to provide it because they lack mental capacity. Only pertinent personal information will be shared.
If a testing unit comes to your home, they will give you instructions and help you complete the test, and test kits will be delivered with staff instructions on how to conduct the test.
Your sample will be sent for analysis after the test has been completed, and the results will be communicated to you and/or the manager. This is due to the fact that the manager will have to take action if you test positive, like moving you to a different area of the residence to lower the risk of infecting other residents or members of the staff.
They will also be informed of the outcome if someone has been appointed legally to manage your affairs (such as someone who has Power of Attorney status for you); however, this does not apply to Power of Attorneys who have been appointed to manage your financial affairs only.
Your GP will also be informed of your results if you live in England so they can determine what care you require. View detailed instructions on care home visits
How we use your data, staff
You are also qualified to take a test. Although taking a test is optional, we strongly advise doing so for the reasons mentioned above.
You can take a test if you're working on the day a testing unit is on site because tests will be administered in the same way. The manager can schedule a home test for you if they come on a day when you are not at work. The kit will be shipped to the residence. You can also register on your own for a test.
The exam will be administered as described above. However, the manager will either of the following when they sign you up for the test:
- ask for your email address and mobile number so that results are sent to you directly.
- Asking you to confirm the accuracy of your email and mobile phone numbers after entering them from your staff record
This will guarantee that you receive your test results rather than the manager.
For staff members, the manager cannot enter home contact information (as they might for residents). To confirm your contact information, you will be given a code to enter into the booking system.
You must notify your employer if you test positive for COVID-19 so that the manager can oversee the home care for you (since you will need to isolate yourself) and for your own personal care and support. Negative test results do not require notification to your employer.
In England, your GP will also receive your results to update your medical records.
Essential visitors and caregivers
Visitors and essential caregivers must adhere to the same testing procedures as staff during both routine asymptomatic testing and an outbreak. The same way that staff described above will be used to process any collected personal data. The care home testing guidance provides additional details on staff testing procedures. Please click the link for each devolved country above if you are a resident of another devolved country.
Self-evaluation and reporting in Annexe 2
Self-testing and reporting may be used in populations with or without symptoms. This enables the test subject to report on their results and register their information along with the test kit ID number. The NHS staff, key workers, care homes, and other settings where self-testing and self-reporting adoption has been deemed appropriate will all be tested using this testing model.
The test-taker's identity as well as their participation in the test will be recorded (for instance, resident, employee, or visitor). From a technological and privacy standpoint, there is nothing more to the data collected to existing Registration Lite services than what the individual self-asserts on the portal.
The self-assessed result (positive, negative, or invalid) is the only piece of information collected by this service that is not requested during Registration Lite.
The test site will be required to collect the first name, last name, and contact phone number of the test participants who have picked up the self-test kits from an authorized location in order to comply with Medicines and Healthcare products Regulatory Agency (MHRA) requirements. In order to fulfill our regulatory obligation to the MHRA in the event of a batch recall, an investigation into adverse incidents, or the issuance of a field safety notice, we must have end-user traceability. We will only use this information to track down the individual.
As part of the self-testing and self-reporting process, test subjects must record their LFD results and submit them to UKHSA. We have a feature that allows a test subject's device camera to read a digital result from the LFD device when the test subject submits it (for example, a mobile phone). We also give you the option to manually enter your results using other methods available on the result submission journey.
This digital LFD reader has the capacity to ascertain a test subject result and submit it to UKHSA on the subject's behalf. When you select this option, Article 22 of the UK GDPR, which addresses the use of automated decision-making, is activated. In essence, this means that without the need for human intervention, our reader can read your LFD device and automatically present a result to you and the Test and Trace service. Your personal data processing activities within UKHSA are authorized by the COPI Notices, which provides legal justification for such processing activities.
There are minor adjustments made to data flows and front-end data capture (which uses the same infrastructure as the majority of your data collection and test result registration). This implies that the various existing downstream systems receive your test results. However, information won't transfer to GP records.
Data will flow down into our analytical systems, where our internal teams can access it for UKHSA reporting purposes. Data will also go to our confirmatory communication provider, who will now send you an SMS or email with the results of your test.
Cohort pooling, Annexe 3
For the UK National Testing Programme, cohort pooling offers a significant opportunity because it can boost testing capacity significantly with little additional investment in capital or interference with current lab procedures while also lowering reagent usage per test.
Sample pooling is a technique that can be used to speed up testing procedures.
Using the same RT-PCR testing procedure, multiple individual samples are combined into a pool for pooling.
A real-time polymerase chain reaction, or RT-PCR, is a molecular biology laboratory technique based on the polymerase chain reaction. Instead of at the end of the PCR like in traditional PCR, it monitors the amplification of a targeted DNA molecule while it is happening.
If a result is negative, it means that each sample in the pool tested negative. A positive result means that at least one of the pool's samples is positive. Then, subsequent testing can be used to attribute specific results, guided by policy decisions. An individual test will be recommended to those who receive a positive test result and will be contacted.
There are a number of use cases for which cohort pooling would be an effective diagnostic tool, even though it only provides a single result for the entire cohort rather than separate results for each subject within the cohort or pool.
For populations with a low prevalence rate (1 to 5%), all pooling techniques, including cohort pooling, offer greater efficiency than individual testing. The necessity of repeat testing to identify positive samples within pools reduces the efficiency gained for populations with a higher prevalence rate (>5%).
Lateral flow testing in Annexe 4
Both symptomatic and asymptomatic populations who are at risk of contracting COVID-19 infection may benefit from lateral flow testing. It is used to reduce the workload on labs, produce results quickly (15 to 20 minutes), enable timely reporting, and find contacts for data subjects who may be infected with COVID-19.
The objective of lateral flow immunochromatographic assays, also referred to as lateral flow devices, is the qualitative detection of SARS-CoV-2 nucleocapsid antigens in human nasal, throat, or saliva samples.
Your sample will be analyzed on-site after you take the test, and you will be informed of the outcome (positive, negative, or unclear). Results will be communicated via an app using current data flows. You will receive guidance on any necessary next steps after receiving your result.
Negative findings should be weighed against a patient's recent exposures, history, and the presence of clinical symptoms and signs consistent with COVID-19, and confirmed with a PCR test, if necessary, for patient management. Your data is handled and used in the same manner as the PCR test described in the comprehensive privacy notice.
We've developed software that can read your LFT device results and determine whether they are a positive, negative, or void result as part of submitting your test results. The software transmits the data to our back-end systems, where all NHS Test and Trace service operations are carried out.
When people are asked to take pictures of their test barcodes as part of this project, no attempt will be made to collect any personally identifiable information.
In the extremely unlikely event that people unintentionally submit personal information when taking pictures of test barcodes, the image will still be processed further. However, if any additional information is added to the image, it cannot be taken out without also deleting the image, so it will stay there.
International arrivals, Annexe 5
If you're coming from abroad to England, you might need to show proof that your COVID-19 test results were negative in order to enter the country. You do not need to take a test before traveling to England if you meet the requirements for being fully immunized.
Before arriving in England from abroad, you must take a COVID-19 test to determine if you meet the requirements for being fully immunized. The test must be taken two days prior to your flight to England. A COVID-19 PCR test must also be scheduled and paid for once you arrive in England.
Such testing must be scheduled before you arrive in the UK.
Additional details on scheduling such tests:
- prior to your trip to England
- once you've reached England
The privacy notice above contains more details about how the devolved nations handle your personal information.
The UKHSA receives the personal information you've given to your testing company for the reasons listed in the section of this privacy notice titled "Purposes for which your data will be used."
Your personal information may need to be processed by UKHSA for the purposes of preventing, detecting, and investigating fraud. This would include whether the exam was scheduled online or using digitally assisted testing. All medical data is excluded from this processing of your personal information, and when legally required, we may also disclose your personal information to law enforcement officials. Your test results wouldn't need to be shared with UKHSA, but we would need to know that the test was taken and passed.
Test to Release methodology
The Test to Release program came to an end on February 11, 2022. After arriving in England, people are no longer required to be in quarantine.
Whether you meet the criteria for being fully immunized under the rules for travel to England will determine what you need to do. The section of this privacy notice titled "Test on Arrival Scheme" contains more details.
Genomic sequencing, Annexe 6
To support the identification and management of variants of concern as part of the COVID-19 testing program, we must be more targeted in the samples we sequence.
The end-to-end process is where the current method used at DHSC for identifying subjects of interest occurs. This implies that samples that should be discarded before identification are those that should be prioritized for sequencing. Additionally, a large number of interesting samples are processed in Lighthouse Laboratories, which lack a formal process for sending these samples for genomic sequencing.
At the moment, the UKHSA is sequencing about 25% of the potential prioritized samples. In order to determine whether you are a "subject of interest," we will ask for information from you during registration.
Direct LAMP Testing in the Test and Trace Program, Annexe 7
Direct LAMP is a laboratory-based testing technology that enhances a variety of test types used for COVID-19 testing, including LFD and PCR.
In some NHS trusts, Direct LAMP is supporting asymptomatic staff testing. Through their lab LIMS (Laboratory Information Management System), the direct LAMP participating laboratories process test results using a digital processing system and submit this data to UKHSA.
In conclusion, you register and submit your data through the portal created by the lab that was hired by your trust to process your direct LAMP test. Following that, the lab submits this UKHSA infrastructure through the UKHSA Second Generation Surveillance System (SGSS) database. After entering the infrastructure, the data will be processed by third parties as is customary, adhering to the established protocols used by the wider UKHSA. Your data is used for the purposes outlined in the privacy notice, which this forms an annex to, as well as to update your general practitioner's medical record.
List of recipients of personal data in Annexe 8,
You must be given information about how each organization uses your data, and this information will only pertain to their part in the test program. This should be accessible to the general public on their website or upon request from them. For instance, you can visit NHS Digital's website to learn more about how they use your information.
Data processors may only act in accordance with written instructions from a data controller; they are prohibited from using data and information without the controller's consent.
Support for Coping with the Passing of Your Feline CompanionLosing a beloved pet can bring about immense emotions of grief and uncertainty. When dealing with the passing of your feline friend, you may be unsure of what steps to take next. To assist you during this challenging time, we provide advice and
Opt for a Scientifically-Proven Learning MethodSome subjects can be mastered independently to attain an A or A* grade. Fortunately, Biology is one of them! There is a straightforward learning technique that can help you achieve this. We refer to it as the scribble technique, highlighted by an Amazon
Do you use your mobile phone to stay in touch with your loved ones, save cherished moments, and work from any location? Do you carry it around with you everywhere you go? Losing your phone or tablet can be a major setback for your personal and professional life. Fortunately, Samsung's range of
If you are concerned about cleaning and sanitizing your dog's wounds, Hibiscrub is a reliable disinfectant that can combat bacteria, viruses, and fungi. Although it is commonly used in medical facilities, you can also use it at home.In this blog post, we will discuss the benefits, side effects, and safe